AGENT emplois en FRANCE
367 Agent emplois en La Défense sur 27 page(-s)
Apprentice Marketing Hematology/Nephrology
Alexion Pharmaceuticals -
-D) as well as the first and only approved Factor Xa inhibitor reversal agent. In addition, the company is developing several mid-to-late...-stage therapies, including a copper-binding agent for Wilson disease, an anti-neonatal Fc receptor (FcRn) antibody for rare...
Alexion Pharmaceuticals -
Levallois-Perret, Hauts-de-Seine
- - 24 Mai 2024-D) as well as the first and only approved Factor Xa inhibitor reversal agent. In addition, the company is developing several mid-to-late...-stage therapies, including a copper-binding agent for Wilson disease, an anti-neonatal Fc receptor (FcRn) antibody for rare...
Alternant(e) – Affaires Médicales Metabo
Alexion Pharmaceuticals -
Factor Xa inhibitor reversal agent. In addition, the company is developing several mid-to-late-stage therapies, including... a copper-binding agent for Wilson disease, an anti-neonatal Fc receptor (FcRn) antibody for rare Immunoglobulin G (IgG...
Alexion Pharmaceuticals -
Levallois-Perret, Hauts-de-Seine
- - 24 Mai 2024Factor Xa inhibitor reversal agent. In addition, the company is developing several mid-to-late-stage therapies, including... a copper-binding agent for Wilson disease, an anti-neonatal Fc receptor (FcRn) antibody for rare Immunoglobulin G (IgG...
Apprentice Marketing Métabo
Alexion Pharmaceuticals -
first and only approved Factor Xa inhibitor reversal agent. In addition, the company is developing several mid-to-late-stage... therapies, including a copper-binding agent for Wilson disease, an anti-neonatal Fc receptor (FcRn) antibody for rare...
Alexion Pharmaceuticals -
Levallois-Perret, Hauts-de-Seine
- - 24 Mai 2024first and only approved Factor Xa inhibitor reversal agent. In addition, the company is developing several mid-to-late-stage... therapies, including a copper-binding agent for Wilson disease, an anti-neonatal Fc receptor (FcRn) antibody for rare...